News

vTv Therapeutics to Engage in Virtual HCW@Home Event Soon

vTv Therapeutics to Engage in Virtual HCW@Home Event Soon

vTv Therapeutics to Engage in Virtual HCW@Home Event Soon

HIGH POINT, N.C. – vTv Therapeutics Inc. (NASDAQ: VTVT), a biopharmaceutical firm at the forefront of diabetes treatment, is excited to share its upcoming participation in the H.C. Wainwright “HCW@Home” Series, taking place virtually. This event is a great opportunity for the company to discuss its innovative approach to managing type 1 diabetes (T1D) through its investigational drug cadisegliatin.

Event Highlights

The “HCW@Home with vTv Therapeutics” event is set for an engaging fireside chat format. The discussion will be moderated by Emily Bodnar, who is the Director at H.C. Wainwright. vTv Therapeutics will feature key personnel, offering insights into their mission and pipeline.

Featured Speakers

Attendees will hear from distinguished voices within vTv Therapeutics, including:

  • Paul Sekhri, who serves as Chairman of the Board, President, and CEO
  • Thomas Strack, MD, Chief Medical Officer
  • Carmen Valcarce, Ph.D., Executive Vice President and Chief Scientific Officer
  • Michael Tung, MD, MBA, Chief Financial Officer

This varied team brings together expertise across fields, demonstrating vTv's commitment to advancing medical science.

Event Timing and Access

The event will occur on Thursday, June 12, starting at 10:00 AM ET. Interested individuals may register online to join this informative session. The company will archive the webcast on its official News & Events page, providing a resource for those unable to attend live.

About vTv Therapeutics

vTv Therapeutics Inc. is dedicated to developing oral therapies targeting chronic diseases, specifically aimed at supporting individuals living with diabetes. Currently, its clinical pipeline is highlighted by cadisegliatin, a cutting-edge glucokinase activator in Phase 3 trials aimed at treating type 1 diabetes. In addition to cadisegliatin, vTv is exploring various molecules targeting multiple indications to address the needs of chronic disease patients.

Corporate Engagement

To stay informed about vTv's latest initiatives and developments, you can follow the company on LinkedIn or visit their website. Engagement with the community helps build a brighter future for patients living with chronic diseases.

Investor Information

If you're an investor or media professional seeking further information, please reach out to the contacts listed below:

Investor Contact

John Fraunces
LifeSci Advisors, LLC
917-355-2395
jfraunces@lifesciadvisors.com

Media Contact

Caren Begun
TellMed Strategies
201-396-8551
caren.begun@tmstrat.com

Frequently Asked Questions

What is cadisegliatin?

Cadisegliatin is a potential first-in-class oral adjunctive therapy to insulin, currently being investigated for treating type 1 diabetes.

When will the HCW@Home event take place?

The event is scheduled for Thursday, June 12, at 10:00 AM ET.

Who will be speaking at the event?

Key executives including Paul Sekhri, Thomas Strack, and Carmen Valcarce among others will present insights at the event.

How can I access the event?

You can register online for the event, and it will also be available for viewing on vTv's website afterward.

What is vTv Therapeutics focused on?

vTv Therapeutics is focused on developing innovative therapies for chronic diseases, particularly emphasizing treatments for diabetes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Houston IP Firm Reaches New Heights in 2027 Rankings

Updated Category News Views 56

Heim, Payne & Chorush: A Legal Powerhouse When you think of top-tier intellectual property firms in the Lone Star State, Heim, Payne & Chorush, LLP isn't just on the list—they're setting the standard. Freshly minted as one of the top dogs in the 2027 Best Law Firms rankings, their accolade-heavy journey screams seasoned expertise. They've nailed down the kind of...

Continue Reading
AI in Finance: Hidden Work Costs Firms Productivity

Updated Category News Views 32

AI's Unseen Burden on Finance Teams Ah, the promise of AI in finance—where's the catch, right? Well, turns out the burden lies with the finance pros themselves. You pour AI over broken, scattered data systems, and you're in for a world of headaches. Accounting Seed's latest research paints a gritty picture of what's happening on the ground in small and midsize...

Continue Reading
Zillow Eases the FHA Down Payment Burden

Updated Category News Views 64

A New Financial Lifeline for Homebuyers In a market where finding a foothold in the housing game feels like scaling Everest without ropes, Zillow Home Loans has tossed a lifeline to potential homeowners. Their latest move might just be what many house hunters needed to hear—offering a hand where it’s been missing for years: down payment assistance for FHA loans. The...

Continue Reading
AAN Seeks Donations to Drive Crucial Brain Research

Updated Category News Views 101

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

Continue Reading
DJI's Matrice 5T: A Power-Packed Aerial Beast

Updated Category News Views 81

DJI's Latest Aerial Workhorse When it comes to drone talk, the new DJI Matrice 5T is the stuff that has everyone buzzing. It's the kind of drone loaded with technology that could make even a hardened stock trader tip their hat. DJI's latest offering isn't just another gadget; it's a full-fledged powerhouse engineered to tackle high-risk environments. Details Worth Looking...

Continue Reading
Coronation Securities: Pioneering Digital Brokerage in Nigeria

Updated Category News Views 30

Coronation Securities: A Digital Revolution Ah, Nigerian financial markets have found themselves a trailblazer, folks. Meet Coronation Securities Limited, recently crowned the 'Fastest Growing Digital Brokerage Platform – Nigeria' at the 2026 Global Brand Awards. Now, that's a nod from Global Brands Magazine worth sitting up for. Turning the Tide with Tech In an...

Continue Reading
Panera Bread Welcomes the Holidays with Style

Updated Category News Views 44

Panera's Holiday Strategy: Sweets and Nostalgia Grab a seat, folks, because Panera Bread is rolling out the holiday red carpet with a strategy that's all about indulgence and memories. They're tossing in limited-edition Snowman Cups and a host of heartwarming treats to shake things up this season. Everyone's buzzing about these collectible cups and sugary delights, and...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 80

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials

Updated Category News Views 78

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Continue Reading
Russel Metals Reports Record Q3 2026 Financial Performance

Updated Category News Views 70

Russel Metals Hits New Highs in Q3 2026 Boy, oh boy, Russel Metals just smashed some serious numbers this quarter. We're talking record-breaking revenues, adjusted EBITDA, and earnings per share. For the third quarter ending September 30, 2026, the company's financials are a good read, especially if you're one of those investors who like real, meaty numbers. Impressive...

Continue Reading

Top 5 Most Recently Viewed Articles

Richmond Habitat Marks 400th Home, 40 Years of Impact

Updated Category News Views 8

Celebrating 400 Homes and 40 Years Think about it: Richmond Habitat for Humanity just dedicated its 400th home in Highland Grove, marking a milestone during their 40th Anniversary Week of Building Hope. This isn’t just some numbers game, folks. It means that 400 families now have what many of us take for granted—a stable, safe place to call home. A Day of Dedication...

Continue Reading
Zeta Global's Strategic Acquisition of LiveIntent for Growth

Updated Category News Views 260

Zeta Global's Strategic Move in the Marketing Sector Zeta Global Holdings Corp. (NYSE: ZETA) is creating ripples in the marketing landscape with its recent announcement of a major acquisition. This acquisition involves purchasing LiveIntent for a total sum of $250 million. The excitement around this strategic decision has contributed to a rise in ZETA shares, showcasing...

Continue Reading
Exploring AI and Blockchain Innovations at KBW 2025 Conference

Updated Category News Views 319

Exploring AI and Blockchain Innovations at KBW 2025 Conference Korea Blockchain Week (KBW), organized by FactBlock, is set to hold its 2025 conference, bringing together leading minds from diverse sectors. During this event, prominent policymakers and thought leaders will come together to discuss the synergy of regulatory frameworks, artificial intelligence (AI), and...

Continue Reading
Samsung Biologics Unveils ExellenS™ for Streamlined Biomanufacturing

Updated Category News Views 257

Samsung Biologics Introduces ExellenS™ for Enhanced Manufacturing Samsung Biologics is redefining the landscape of biomanufacturing with the launch of ExellenS™, a robust framework that aims to optimize production across its network of facilities. This innovative approach reflects the company's commitment to maintaining excellence in operational processes and...

Continue Reading
Exclusive Auction for Former School Properties in Dillon

Updated Category News Views 322

A Unique Opportunity for Investors in Dillon Excitement is building as a remarkable Absolute Real Estate Auction takes place, featuring former school properties and their contents up for bid to the highest offer. This unique auction presents an exceptional chance for buyers to acquire assets that not only hold historical significance but also have substantial investment...

Continue Reading